218 related articles for article (PubMed ID: 17189472)
1. Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator.
Stogios PJ; Chen L; Privé GG
Protein Sci; 2007 Feb; 16(2):336-42. PubMed ID: 17189472
[TBL] [Abstract][Full Text] [Related]
2. The BCL-6 POZ domain and other POZ domains interact with the co-repressors N-CoR and SMRT.
Huynh KD; Bardwell VJ
Oncogene; 1998 Nov; 17(19):2473-84. PubMed ID: 9824158
[TBL] [Abstract][Full Text] [Related]
3. Novel BTB/POZ domain zinc-finger protein, LRF, is a potential target of the LAZ-3/BCL-6 oncogene.
Davies JM; Hawe N; Kabarowski J; Huang QH; Zhu J; Brand NJ; Leprince D; Dhordain P; Cook M; Morriss-Kay G; Zelent A
Oncogene; 1999 Jan; 18(2):365-75. PubMed ID: 9927193
[TBL] [Abstract][Full Text] [Related]
4. Structure of the POZ domain of human LRF, a master regulator of oncogenesis.
Schubot FD; Tropea JE; Waugh DS
Biochem Biophys Res Commun; 2006 Dec; 351(1):1-6. PubMed ID: 17052694
[TBL] [Abstract][Full Text] [Related]
5. In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions.
Melnick A; Ahmad KF; Arai S; Polinger A; Ball H; Borden KL; Carlile GW; Prive GG; Licht JD
Mol Cell Biol; 2000 Sep; 20(17):6550-67. PubMed ID: 10938130
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of SMRT corepressor recruitment by the BCL6 BTB domain.
Ahmad KF; Melnick A; Lax S; Bouchard D; Liu J; Kiang CL; Mayer S; Takahashi S; Licht JD; Privé GG
Mol Cell; 2003 Dec; 12(6):1551-64. PubMed ID: 14690607
[TBL] [Abstract][Full Text] [Related]
7. Overexpression, purification, characterization, and crystallization of the BTB/POZ domain from the PLZF oncoprotein.
Li X; Lopez-Guisa JM; Ninan N; Weiner EJ; Rauscher FJ; Marmorstein R
J Biol Chem; 1997 Oct; 272(43):27324-9. PubMed ID: 9341182
[TBL] [Abstract][Full Text] [Related]
8. Structure-function studies of the BTB/POZ transcriptional repression domain from the promyelocytic leukemia zinc finger oncoprotein.
Li X; Peng H; Schultz DC; Lopez-Guisa JM; Rauscher FJ; Marmorstein R
Cancer Res; 1999 Oct; 59(20):5275-82. PubMed ID: 10537309
[TBL] [Abstract][Full Text] [Related]
9. The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.
Deweindt C; Albagli O; Bernardin F; Dhordain P; Quief S; Lantoine D; Kerckaert JP; Leprince D
Cell Growth Differ; 1995 Dec; 6(12):1495-503. PubMed ID: 9019154
[TBL] [Abstract][Full Text] [Related]
10. Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors.
Melnick A; Carlile G; Ahmad KF; Kiang CL; Corcoran C; Bardwell V; Prive GG; Licht JD
Mol Cell Biol; 2002 Mar; 22(6):1804-18. PubMed ID: 11865059
[TBL] [Abstract][Full Text] [Related]
11. Novel human BTB/POZ domain-containing zinc finger protein ZNF295 is directly associated with ZFP161.
Wang J; Kudoh J; Takayanagi A; Shimizu N
Biochem Biophys Res Commun; 2005 Feb; 327(2):615-27. PubMed ID: 15629158
[TBL] [Abstract][Full Text] [Related]
12. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein.
Dhordain P; Albagli O; Lin RJ; Ansieau S; Quief S; Leutz A; Kerckaert JP; Evans RM; Leprince D
Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10762-7. PubMed ID: 9380707
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the BTB domain from PLZF.
Ahmad KF; Engel CK; Privé GG
Proc Natl Acad Sci U S A; 1998 Oct; 95(21):12123-8. PubMed ID: 9770450
[TBL] [Abstract][Full Text] [Related]
14. A beta-sheet interaction interface directs the tetramerisation of the Miz-1 POZ domain.
Stead MA; Trinh CH; Garnett JA; Carr SB; Baron AJ; Edwards TA; Wright SC
J Mol Biol; 2007 Nov; 373(4):820-6. PubMed ID: 17880999
[TBL] [Abstract][Full Text] [Related]
15. Point mutations in BCL6 DNA-binding domain reveal distinct roles for the six zinc fingers.
Mascle X; Albagli O; Lemercier C
Biochem Biophys Res Commun; 2003 Jan; 300(2):391-6. PubMed ID: 12504096
[TBL] [Abstract][Full Text] [Related]
16. Leukemia/lymphoma-related factor, a POZ domain-containing transcriptional repressor, interacts with histone deacetylase-1 and inhibits cartilage oligomeric matrix protein gene expression and chondrogenesis.
Liu CJ; Prazak L; Fajardo M; Yu S; Tyagi N; Di Cesare PE
J Biol Chem; 2004 Nov; 279(45):47081-91. PubMed ID: 15337766
[TBL] [Abstract][Full Text] [Related]
17. Regulation of pokemon 1 activity by sumoylation.
Roh HE; Lee MN; Jeon BN; Choi WI; Kim YJ; Yu MY; Hur MW
Cell Physiol Biochem; 2007; 20(1-4):167-80. PubMed ID: 17595526
[TBL] [Abstract][Full Text] [Related]
18. Osteoclast-derived zinc finger (OCZF) protein with POZ domain, a possible transcriptional repressor, is involved in osteoclastogenesis.
Kukita A; Kukita T; Ouchida M; Maeda H; Yatsuki H; Kohashi O
Blood; 1999 Sep; 94(6):1987-97. PubMed ID: 10477728
[TBL] [Abstract][Full Text] [Related]
19. Functional studies of the BTB domain in the Drosophila GAGA and Mod(mdg4) proteins.
Read D; Butte MJ; Dernburg AF; Frasch M; Kornberg TB
Nucleic Acids Res; 2000 Oct; 28(20):3864-70. PubMed ID: 11024164
[TBL] [Abstract][Full Text] [Related]
20. BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.
Okabe S; Fukuda T; Ishibashi K; Kojima S; Okada S; Hatano M; Ebara M; Saisho H; Tokuhisa T
Mol Cell Biol; 1998 Jul; 18(7):4235-44. PubMed ID: 9632807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]